All companies › MAIA

MAIA · MAIA Biotechnology, Inc.

Everything on this page is public record — SEC Form 4 filings and congressional disclosures — alongside any INSIDER SCANNER research case for this company.

Open-market buys7
Open-market sells0
Total purchased$352,426
Unique insiders buying2
Most senior buyerCEO
Avg price paid$1.37
Research cases0
Last filing2026-09-14

Average price paid is weighted by shares, so a large purchase counts for more than a small one. It is what insiders reported paying, not a target or a fair value.

Insider flow: Buying only — a count of disclosed transactions, not a rating or a recommendation.

Insider transaction timeline

Every reported transaction, positioned by trade date. Purchases sit above the axis, sales below; circle area is proportional to dollar value. No share-price line is drawn — this feed carries transaction prices only, and a price history inferred from them would imply market data the filings do not contain.

Open-market purchase Open-market sale
2026-08-20 — Guerrero Ramiro · bought 11,899 @ $1.37 2026-08-24 — Guerrero Ramiro · bought 1,794 @ $1.33 2026-08-26 — Guerrero Ramiro · bought 8,931 @ $1.39 2026-08-27 — Guerrero Ramiro · bought 78,239 @ $1.39 2026-08-28 — Guerrero Ramiro · bought 46,620 @ $1.35 2026-09-10 — Guerrero Ramiro · bought 37,595 @ $1.32 2026-09-14 — Vitoc Vlad · bought 73,000 @ $1.37
2026-08-202026-09-14

Insider cost basis

Share-weighted average price across 7 reported purchases, with the full range of prices paid. Purchases only — averaging a sale into an "insider cost" would describe a price nobody paid.

$1.32 $1.39
$1.37 weighted average insider purchase price

Insider participation

One row per insider, one cell per reported transaction, shaded by value. Repeat buying and activity clustered in time are visible at a glance.

Guerrero Ramiro Director
Vitoc Vlad Chief Executive Officer, Director, 10% owner
Included with a free account

The analysis built on top of these filings

The filings above are public record and stay public here. What an account adds for $MAIA is the reading of them — and for this company, that is what the list below says it is, no more.

  • Insider cost basisShare-weighted average price paid across the 7 reported purchases, with the full range, against the current price.
  • Insider participationWho bought, how often, and how the buying is distributed across the people filing — one person repeating is not several agreeing.
  • Transaction timelineThe [{'transaction_date': '2026-09-14', 'insider_name': 'Vitoc Vlad', 'insider_title': 'Chief Executive Officer, Director, 10% owner', 'transaction_type': 'Open-market buy', 'shares': 73000.0, 'price': 1.37, 'value': 100010.0, 'is_buy': True}, {'transaction_date': '2026-09-10', 'insider_name': 'Guerrero Ramiro', 'insider_title': 'Director', 'transaction_type': 'Open-market buy', 'shares': 37595.0, 'price': 1.32, 'value': 49625.4, 'is_buy': True}, {'transaction_date': '2026-08-28', 'insider_name': 'Guerrero Ramiro', 'insider_title': 'Director', 'transaction_type': 'Open-market buy', 'shares': 46620.0, 'price': 1.35, 'value': 62937.0, 'is_buy': True}, {'transaction_date': '2026-08-27', 'insider_name': 'Guerrero Ramiro', 'insider_title': 'Director', 'transaction_type': 'Open-market buy', 'shares': 78239.0, 'price': 1.39, 'value': 108752.21, 'is_buy': True}, {'transaction_date': '2026-08-26', 'insider_name': 'Guerrero Ramiro', 'insider_title': 'Director', 'transaction_type': 'Open-market buy', 'shares': 8931.0, 'price': 1.39, 'value': 12414.09, 'is_buy': True}, {'transaction_date': '2026-08-24', 'insider_name': 'Guerrero Ramiro', 'insider_title': 'Director', 'transaction_type': 'Open-market buy', 'shares': 1794.0, 'price': 1.33, 'value': 2386.02, 'is_buy': True}, {'transaction_date': '2026-08-20', 'insider_name': 'Guerrero Ramiro', 'insider_title': 'Director', 'transaction_type': 'Open-market buy', 'shares': 11899.0, 'price': 1.37, 'value': 16301.63, 'is_buy': True}] reported transactions plotted over the window rather than listed, so concentration is visible.

Not available for MAIA today: no research case — nothing here has cleared the scoring threshold. Both appear on this page on their own if that changes.

A free account opens all of it.

Not financial advice. This page reports public filings and past research output. It is not a recommendation to buy or sell, and no price target here is a prediction. Trade at your own risk.